Danielle Boyle: Honoured to Chair ITP Symposium at the EHA 2026
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, shared on LinkedIn:
”I’m incredibly honoured to be chairing an upcoming symposium at the EHA 2026 Congress next month.
To not only be invited to contribute but also to chair a panel of such highly esteemed clinicians, alongside a fellow patient advocate, is something I’m genuinely proud of.
These are individuals who are shaping the future of ITP care, and it is a privilege to help guide an important and meaningful discussion while continuing to keep patients at the centre of everything we strive to achieve.
What makes this opportunity even more significant is what it represents.
Seeing patient organisations included at this level is a strong step in the right direction and a clear reflection of the shift towards putting patients at the centre of care, research, and decision-making.
This is exactly where we need to be.
Collaborative, inclusive, and grounded in lived experience alongside clinical expertise.
If you are attending EHA 2026 this year, I would love for you to join us.
You can find the session details.
I am looking forward to being part of the conversation and continuing to advocate for a more patient-centred future in ITP.”
Stay updated with Hemostasis Today.
-
May 22, 2026, 00:40Quentin Van Thillo: UZ Leuven Is Recognized as an HHT Center of Excellence
-
May 21, 2026, 22:40David Cairns: Women Often Don’t Know Their Stroke Risk and That’s What We’re Trying to Change
-
May 21, 2026, 21:00Louise St. Germain Bannon: ETHA Launches European Antithrombotic Stewardship Survey Supported by ISTH
-
May 21, 2026, 20:07Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health – Europe
-
May 21, 2026, 19:05Christopher Pittman: Why You Have 3 ‘Hearts’
-
May 21, 2026, 18:58An excellent first cohort for the European Inter-University Certificate in Clinical Haemostasis – CRH French Reference Center for Hemophilia Lyon
-
May 21, 2026, 18:46Gurpreet Kaur Sagoo: The Power of AI Based Morphological Fingerprinting in Predicting Myelofibrosis Progression
-
May 21, 2026, 16:22Konstantin Yenkoyan: Neuroscience Week 2026 Continues in Yerevan
-
May 21, 2026, 16:21Ifeanyichukwu Ifechidere: Rebalanced Haemostasis in Liver Disease